CN Stock MarketDetailed Quotes

002653 Haisco Pharmaceutical Group

Watchlist
  • 33.80
  • -0.43-1.26%
Trading Mar 7 14:16 CST
37.85BMarket Cap79.53P/E (TTM)

Haisco Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Haisco Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 30, 20242024/Q31.065B / 1.182B--
Aug 16, 20242024/Q2934.510M / 954.000M--
Apr 20, 20242024/Q1752.134M / 782.000M--
--2023/Q4971.132M / 1.114B--
DatePeriodRevenue/EstimateEarnings Call
Oct 30, 20242024/Q31.065B / 1.182B--
Aug 16, 20242024/Q2934.510M / 954.000M--
Apr 20, 20242024/Q1752.134M / 782.000M--
--2023/Q4971.132M / 1.114B--
--------

Unlock Free Earnings Estimates

Haisco Pharmaceutical Group Earnings Reports

  • HiCisco: Q3 2024 Report

    Oct 30, 2024 00:00

  • Haisco Pharmaceutical Group: Summary of Half-Year Report in 2024.

    Aug 16, 2024 00:00

  • Haisco Pharmaceutical Group: Half-year report for the year 2024.

    Aug 16, 2024 00:00

  • Haisco Pharmaceutical Group: 2024 semi-annual results forecast

    Jul 12, 2024 00:00

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    NEW WELLLINK
    871634
    28.08 +30.00%
    VIBO
    871245
    57.69 +29.99%
    REFORMER
    833030
    37.03 +29.98%
    MTD
    835579
    31.78 +28.25%
    ZHTD
    836263
    19.00 +21.95%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 7, 2025

    Strong Buy

    • Strong Buy

      83.33%

    • Buy

      16.67%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Western Development
    Western Development
    Intraday-0.04%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-0.30%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday-0.30%